FR940822-0-00033 FR940822-0-00009 (1) The vaccine is sold by the manufacturer after August 10, 1993; and (2) In the case of vaccine sold to, or sold for resale to, the United States or any of its agencies or instrumentalities, the United States or such agency or instrumentality notifies the manufacturer that the vaccine is intended for uses other than the vaccination of persons described in 42 U.S.C. 300aa&hyph;11(c)(1)(B)(i)(II) (relating to certain U.S. citizens who are vaccinated outside the United States). Par. 4. Section 48.6416(b)(2)&hyph;2 is amended by: 1. Redesignating the text of paragraph (b) following the heading as paragraph (b)(1). 2. Adding a heading to paragraph (b)(1). 3. Revising the first sentence of paragraph (b)(1). 4. Adding paragraph (b)(2). 5. The revisions and additions read as follows: ยง48.6416(b)(2)&hyph;2 Exportations, uses, sales, and resales included. * * * * * (b) Exportation of tax-paid articles _(1) In general. Subject to the limitations of section 6416(b)(2) and paragraph (b)(2) of this section, tax paid under chapter 31 or 32 on the sale of any article will be considered to be an overpayment under section 6416(b)(2)(A) if the article is exported by any person. * * * (2) Rule for exportation of vaccines. Paragraph (b)(1) of this section applies to tax paid under section 4131 on the sale of a vaccine, but only if the sale by the manufacturer occurs after August 10, 1993, and, in the case of vaccine sold to the United States or any of its agencies or instrumentalities, the condition of ยง48.4221&hyph;3(e)(2) is satisfied. * * * * * Margaret Milner Richardson, Commissioner of Internal Revenue. Approved: July 21, 1994. Leslie Samuels, Assistant Secretary of the Treasury. [FR Doc. 94&hyph;20222 Filed 8&hyph;19&hyph;94; 8:45 am] BILLING CODE 4830&hyph;01&hyph;U
